Windtree to raise up to $200M for BNB crypto treasury strategy

Nasdaq-listed biotech company Windtree Therapeutics signed a $60 million deal with Build and Build Corp, with potential to raise up to $200 million, to launch a BNB-focused crypto treasury strategy, according to Business Insider. Pending approval, Windtree would become the first Nasdaq-listed company offering direct exposure to BNB.